# 1 each (15.3*)

**Page range:** 53â€“54

```text
1 each (15.3*)

54
Drug Safety Report No: 1132062
*Percentage is provided as combined for all the Preferred terms mentioned in the respective row
Cases reporting opportunistic infections
A total of 27 cases reported 28 PTs of opportunistic infections namely, Pneumocystis
pneumonia, Herpes zoster (n=6), Pneumonia legionella (n=5), Pneumonia
cytomegaloviral (n=3), Proteus, Varicella, Proteus infection, Klebsiella urinary tract
infection, Cryptococcus, Sinusitis aspergillus, Klebsiella bacteremia, Pneumocystis
jirovecii infection and Pneumonia klebsiella (n=1 each). The latency for the events
ranged from 21 to 1825 days. The outcome for the events were resolved/resolved with
sequelae in 25, not resolved in 1 and resolving in 1. In 6 of these 27 cases there was
evidence of co-existing lymphopenia/leucopenia.
Event outcome by action taken
Table 19 presents the action taken with pralsetinib in response to the event.
Table 19 Summary of Event Outcome by action taken for Grade 3 Infection
AEs from Safety Database
Event outcome
Action taken with the drug
Dose
interrupted
Dose
reduced
Drug
withdrawn
Dose
not
changed
Not
applicable
Not
reported
Recovered/Resolved
159
1
4
40
10
32
Recovered/Resolved
with sequelae
26
1
1
4
0
```